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Abstract
Background:  Patients  presenting  with  Barrett’s  esophagus  (BE)  should  be  under  life-long  surveil-
lance in  an  attempt  to  detect  cancer  in  its  early  stages.  Esophageal  capsule  endoscopy  (ECE)  is
a new  technique  that  enables  a  noninvasive  evaluation  of  the  esophagus.
Aims: To  evaluate  ECE  effectiveness  compared  with  methylene  blue  (MB)  chromoendoscopy
for the  detection  of  esophageal  lesions  in  which  there  was  suspicion  of  cancer,  the  length  and
pattern of  BE,  and  the  presence  of  hiatal  hernia.
Material  and  methods:  Twenty-one  patients  with  BE  who  underwent  Nissen  fundoplication  and
had a  follow-up  period  of  more  than  ﬁve  years  were  prospectively  enrolled  in  the  study.  The
patients underwent  ECE  and  chromoendoscopy  with  MB  performed  by  different  physicians  who
were blinded  to  each  of  the  procedures.
Results:  ECE  sensitivity,  negative  predictive  value,  and  accuracy  were  100%,  100%,  and  79%,
respectively,  for  the  detection  of  esophageal  lesions  suspected  of  cancer.  ECE  accuracy  in
assessing  BE  length  was  89%  and  in  the  evaluation  of  ﬁnger-like  projections,  circumferential
BE, and  mixed  BE  was  74%,  79%,  and  74%,  respectively.
In relation  to  hiatal  hernia  detection,  ECE  sensitivity  was  43%  and  its  accuracy  was  74%.
Conclusions:  ECE  appears  to  be  a  good  method  for  detecting  lesions  in  which  there  is  suspicion
of esophageal  cancer  and  it  had  modest  results  in  regard  to  the  accurate  identiﬁcation  of  BE
length and  pattern.  ECE  is  not  a  good  method  for  detecting  hiatal  hernia.  Further  studies  are
needed in  order  to  deﬁne  the  deﬁnitive  role  of  ECE  in  BE  monitoring.
© 2012  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  All
rights reserved.
 See Editorial in pages 55--6.
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Evaluación  comparativa  del  epitelio  del  esófago  de  Barrett  por  la  cápsula
endoscópica  del  esófago  y  la  cromoendoscopia  con  azul  de  metileno
Resumen
Antecedentes:  Los  pacientes  con  esófago  de  Barrett  (EB)  deben  ser  seguidos  durante  toda  la
vida en  un  intento  de  detectar  el  cáncer  en  una  etapa  temprana.  La  cápsula  endoscópica  del
esófago (CEE)  es  una  nueva  tecnología  que  permite  la  evaluación  no  invasiva  del  esófago.
Objetivos:  Evaluar  la  eﬁcacia  de  la  CEE  en  comparación  con  la  cromoendoscopia  con  azul  de
metileno (AM)  para  la  detección  de  lesiones  sospechosas  de  cáncer  de  esófago,  longitud  y  patrón
de EB,  y  la  presencia  de  hernia  hiatal.
Materiales  y  métodos: Veintiún  pacientes  con  Barrett  sometidos  a  funduplicatura  de  Nissen,
con más  de  5  an˜os  de  seguimiento,  fueron  incorporados  prospectivamente.  Los  pacientes  fueron
sometidos  a  la  CEE  y  a  cromoendoscopia  con  AM  por  diferentes  medicos,  cegados  a  cada  uno
de los  procedimientos.
Resultados:  La  sensibilidad,  el  valor  predictivo  negativo  y  precisión  de  la  CEE  fueron  del  100,  el
100 y  el  79%,  respectivamente,  para  la  detección  de  lesiones  sospechosas  de  cáncer  de  esófago.
La precisión  de  la  CEE  para  la  evaluación  de  la  longitud  del  EB  fue  del  89%.  La  precisión  de  la
CEE para  la  evaluación  de  las  proyecciones  digitiformes,  circunferencial  y  EB  mixto  fue  del  74,
el 79  y  el  74%,  respectivamente.
La sensibilidad  de  la  CEE  y  la  precisión  para  la  detección  de  hernia  hiatal  fueron  del  43  y  el
74%, respectivamente.
Conclusiones:  La  CEE  parece  ser  un  buen  método  para  la  detección  de  lesiones  sospechosas  de
cáncer de  esófago.  Con  respecto  a  la  identiﬁcación  precisa  de  la  longitud  y  el  patrón  del  EB,  la
CEE tuvo  resultados  modestos.  La  CEE  no  es  un  buen  método  para  la  detección  de  una  hernia
hiatal. Son  necesarios  más  estudios  para  deﬁnir  el  papel  deﬁnitivo  de  la  CEE  en  el  seguimiento
de EB.
© 2012  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Todos los  derechos  reservados.
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astroesophageal  reﬂux  disease  (GERD)  and  its  complica-
ions,  including  Barrett’s  esophagus  (BE),  are  common  public
ealth  issues  that  have  experienced  signiﬁcant  growth  rates
n  developed  countries.  It  is  estimated  that  50%  of  adults  in
he  United  States  experience  GERD  symptoms  each  month,
nd  14--20%  report  that  their  symptoms  occur  at  least  once
 week.1,2 GERD  is  associated  with  a  signiﬁcant  decrease
n  the  quality  of  life  and  enormous  economic  costs,  with
irect  costs  exceeding  US$10  billion  and  indirect  costs  of
pproximately  US$5  billion  per  year.3
BE  occurs  in  approximately  10%  of  patients  with  GERD4
nd  is  characterized  by  the  replacement  of  the  normal
tratiﬁed  squamous  epithelium  of  the  esophagus  with  colum-
ar  epithelium  containing  intestinalized  cells  in  any  part
f  the  organ.5,6 The  main  clinical  signiﬁcance  of  BE  is  its
tatus  as  a  predisposing  condition  for  adenocarcinoma  of
he  esophagus;  the  incidence  of  which  has  increased  sub-
tantially  in  the  United  States,  Western  Europe,  Australia,
nd  other  developed  parts  of  the  world  over  the  last  four
ecades.7,8 Once  a  person  develops  BE,  neither  clinical  nor
urgical  treatments  for  GERD  can  prevent  the  progression
f  BE  to  adenocarcinoma.9--11 Thus,  endoscopic  monitoring
f  patients  with  BE  is  routinely  used  for  early  detection
f  esophageal  adenocarcinoma,  with  the  goal  of  reducing
ortality.12,13
Currently,  the  gold  standard  for  monitoring  patients  with
E  is  a  series  of  upper  gastrointestinal  endoscopic  biopsies
t
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trom  four  quadrants,  obtained  from  every  1--2  cm  and,  if
resent,  from  any  areas  of  mucosal  irregularity.14 Tech-
iques  such  as  chromoendoscopy  with  methylene  blue  can
e  used  to  facilitate  the  identiﬁcation  of  BE  and,  more
mportantly,  areas  of  intraepithelial  neoplasia  and  early  car-
inoma.  Several  studies  have  shown  that  methylene  blue
hromoendoscopy  increases  the  detection  rate  of  early  neo-
lasia  in  BE  and  reduces  the  number  of  biopsies  needed
ompared  with  conventional  endoscopy  with  randomized
iopsies.15,16 The  cost,  invasiveness,  discomfort,  need  for
edation,  and  absence  from  work  are  potential  obstacles  to
he  widespread  use  of  upper  gastrointestinal  endoscopy.17,18
he  need  for  a  less  invasive,  safer,  and  reliable  exam  has
enerated  great  interest  in  the  study  of  esophageal  capsule
ndoscopy  (ECE).19
ECE,  which  was  approved  by  the  FDA  in  November
004,  is  a  new  tool  that  allows  visualization  of  the  esoph-
gus  and  is  associated  with  less  discomfort  and  fewer
isks  than  conventional  upper  gastrointestinal  endoscopy
UGE).18 Although  several  studies  have  evaluated  the  accu-
acy  of  ECE  for  the  diagnosis  of  BE,  data  on  follow-up  remain
carce.
The  primary  aims  of  this  prospective,  blind  study  were
o  evaluate  the  accuracy  of  ECE  in  the  detection  of  lesions
uspected  to  be  esophageal  cancer  in  patients  with  BE  and
o  evaluate  the  characteristics  of  BE  according  to  length
nd  pattern.  As  secondary  objectives,  we  evaluated  the
ccuracy  of  ECE  for  the  detection  of  hiatal  hernia  and  the
olerability  and  safety  of  the  procedure  in  general.
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Methods
Patients
This  study  was  conducted  at  the  Gastrointestinal  Endoscopy
Unit  of  the  University  of  São  Paulo  School  of  Medicine
(São  Paulo,  Brazil)  from  March  to  September  2008.  Patients
who  had  BE  and  had  undergone  Nissen  fundoplication  were
referred  for  evaluation  according  to  the  following  inclusion
criteria:  age  18  years  or  older,  BE  that  was  diagnosed  by
histology  at  least  ﬁve  years  prior  to  the  study,  previous  treat-
ment  with  Nissen  fundoplication  at  least  ﬁve  years  prior  to
the  study,  and  the  ability  to  provide  written  informed  con-
sent.  Exclusion  criteria  were:  swallowing  disorders,  Zenker
diverticulum,  obstructions  of  the  esophagus,  stenosis  of  the
esophagus,  gastrointestinal  ﬁstulas  (known  or  suspected),
previous  esophageal  surgery,  previous  diagnosis  of  neoplasia
in  BE,  prior  endoscopic  treatment  of  BE,  a  cardiac  pace-
maker,  pregnancy,  a  history  of  allergies  to  dyes,  the  inability
to  undergo  intravenous  sedation,  and  refusal  to  sign  the
informed  consent.
Esophageal  capsule  endoscopy
The  Given  Diagnostic  System  (PillCam  ESO,  Given  Diagnos-
tic  System:  Given  Imaging,  Yoqneam,  Israel)  used  for  this
study  consists  of  three  main  components:  an  esophageal
capsule  endoscope,  a  PillCam  data  recorder  and  a  RAPID
workstation.  The  ECE  is  a  cylindrical  capsule  that  measures
11  mm  ×  26  mm  and  weighs  3.7  g.  It  has  two  convex  opti-
cal  domes  where  images  can  be  captured  at  a  speed  of  two
frames  per  second  per  side  for  a  total  of  four  images  per
second.  The  images  are  transmitted  by  radio  to  the  data
recorder  via  sensors  that  were  previously  attached  to  the
thoracic-abdominal  wall  of  the  patient.  At  the  end  of
the  examination,  the  data  recorder  is  connected  to  the
RAPID  workstation,  and  the  captured  images  are  ready  to
be  evaluated.
Patients  were  instructed  to  fast  for  8  h  prior  to  the  test.
Before  each  test,  the  system  was  prepared,  and  the  sensors
were  positioned  in  the  abdomen  and  chest  of  the  patient.
Next,  the  patient  swallowed  the  ECE  according  to  a  stan-
dardized  protocol.  Patients  were  instructed  to  drink  100  ml
of  water  to  remove  the  secretions  that  cover  the  esoph-
agus.  They  were  then  placed  on  a  gurney  in  the  supine
position,  and  they  ingested  the  endoscopy  capsule  along
with  10  ml  of  water.  After  2  min  in  this  position,  the  hos-
pital  gurney  angle  was  raised  to  30◦,  and  the  patient  was
kept  in  this  position  for  1  min.  The  gurney  was  then  tilted
to  60◦ for  1  min.  Finally,  the  gurney  was  raised  to  90◦,
and  the  patient  remained  seated  in  this  position  for  1  min.
Patients  were  asked  not  to  speak  or  make  sudden  move-
ments  during  the  6-min  test.  The  same  physician,  who  did
not  have  access  to  the  test  results  from  the  UGE  exami-
nation,  evaluated  all  the  ECE  exams.  The  data  parameters
analyzed  by  the  researcher  were  the  esophageal  transit
time,  quality  of  preparation  of  the  esophagus,  presence
or  absence  of  lesions  indicative  of  esophageal  cancer,  esti-
mated  length  of  BE,  BE  pattern  and  the  presence  or  absence
of  a  hiatal  hernia.  The  esophageal  transit  time  was  calcu-
lated  by  subtracting  the  time  of  the  ﬁrst  esophageal  image
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rom  the  time  of  the  ﬁrst  gastric  image.  The  quality  of
he  esophageal  preparation  was  classiﬁed  as  good,  fair,  or
oor.  Lesions  suspected  of  neoplasia  included  raised,  ﬂat,
r  depressed  lesions  located  in  regions  of  BE.  The  BE  was
lassiﬁed  as  long  (≥3  cm)  or  short  (<3  cm)  based  on  its  esti-
ated  length.  With  regards  to  the  pattern  found,  the  BE
as  classiﬁed  as  ﬁnger-like  when  it  was  shaped  as  one  or
ore  columns;  as  circumferential  when  it  surrounded  the
rgan  with  similar  length,  and  as  mixed  when  both  aspects
ere  present,  that  is,  if  the  BE  had  distal  circumferential
nvolvement  with  digitiform  projections  on  its  proximal  por-
ion.
pper  gastrointestinal  endoscopy  combined
ith chromoendoscopy  with  methylene  blue
ll  patients  underwent  UGE  on  the  same  day  that  they
nderwent  the  ECE  examination,  with  the  UGE  always  per-
ormed  after  the  ECE.  All  examinations  were  performed  by
n  experienced  endoscopist  and  were  supervised  by  a  sin-
le  physician,  neither  of  whom  had  access  to  the  results
f  the  ECE  examinations.  A  topical  anesthetic  spray  con-
aining  lidocaine  and  an  intravenous  solution  of  midazolam
nd  fentanyl  citrate  were  used  for  UGE.  All  examinations
ere  performed  with  a standard  video  endoscope  (Olym-
us,  GIF  V;  Olympus  Optical  Co.,  São  Paulo,  Brazil).  First,
he  esophageal  mucosa  was  cleaned  with  a  solution  of  0.9%
aline  and  10%  N-acetylcysteine.  After  2  min,  the  distal
sophagus  was  ﬂushed  with  a 0.5%  methylene  blue  solu-
ion.  Two  minutes  after  the  ﬂush,  excess  methylene  blue  was
ushed  away  with  distilled  water.  Staining  was  considered
ositive  when  the  mucosa  remained  blue  after  washing.  Non-
tained  areas  within  Barrett’s  epithelium  were  considered
uspicious  for  dysplasia,  as  well  as  mucosal  abnormali-
ies  such  as  nodules,  plaques,  ulcers,  erosions,  or  focally
epressed  areas.  Random  4-quadrant  biopsies  every  2  cm
ere  taken  from  all  patients,  and  target  biopsies  were
aken  from  suspicious  areas  when  encountered.  All  speci-
ens  were  examined  by  an  experienced  pathologist.  When
igh-grade  dysplasia  or  adenocarcinoma  was  suspected,  a
econd  pathologist  reviewed  the  sample  to  conﬁrm  diagno-
is.
The  length  of  the  BE  was  deﬁned  as  the  difference
etween  the  distance  from  the  incisors  to  the  esophagogas-
ric  junction  and  the  distance  from  the  incisors  to  the
roximal  margin  of  the  BE.  The  BE  was  classiﬁed  as  long
≥3  cm)  or  short  (<3  cm).  In  regard  to  BE  pattern,  it  was
lassiﬁed  as  ﬁnger-like,  circumferential  or  mixed,  as  previ-
usly  described.  The  potential  presence  of  a  hiatal  hernia
as  investigated,  and  the  size  of  the  hernia  (if  present)
as  measured  as  the  distance  between  the  esophagogastric
unction  and  the  diaphragmatic  pinch.
Three  days  after  the  examination,  patients  were  asked
bout  the  degree  of  discomfort  they  experienced  during  the
CE  and  UGE  examinations.
tatistical  analysisGE  with  esophageal  chromoendoscopy  was  considered  to
e  the  gold  standard  method.  To  compare  the  results
btained  with  ECE  to  those  obtained  with  UGE,  we  calcu-
6 T.A.  Domingos  et  al.
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Table  2  Detection  of  long  BE:  ECE  vs.  UGE.
Long  BE  UGE  Total
No  Yes
ECE
No  2  1  3
Yes 1  15  16
Quantity  3  16  19
Sensitivity  94%
Speciﬁcity  67%
PPV 94%
NPV 67%
Accuracy  89%
Kappa (p-value)  0.60  (0.004)
ECE: esophageal capsule endoscopy; UGE: upper gastrointesti-
nal endoscopy; PPV: positive predictive value; NPV: negative
predictive value.
Table  3  Detection  of  short  BE:  ECE  vs.  UGE.
Short  BE  UGE  Total
No  Yes
ECE
No  15  1  16
Yes 1 2  3
Quantity  16  3  19
Sensitivity  67%
Speciﬁcity  94%
PPV 67%
NPV 94%
Accuracy  89%0  
ated  the  sensitivity,  speciﬁcity,  positive  predictive  value
PPV),  negative  predictive  value  (NPV),  and  accuracy  of  each
ethod.  We  also  calculated  the  Kappa  index  of  agreement.
e  used  the  Fisher  exact  test  to  determine  whether  there
as  an  association  between  the  examination  discomfort  lev-
ls  of  the  ECE  and  UGE  methods.  A  signiﬁcance  level  of  5%
p  ≤  0.05)  was  used  for  all  tests.
esults
 total  of  21  patients  met  the  criteria  for  inclusion  and  were
nrolled  in  the  study.  Two  patients  were  excluded  because
valuation  by  ECE  became  impossible:  one  due  to  inade-
uate  esophageal  preparation,  and  one  due  to  esophageal
tenosis.  Of  the  19  remaining  patients,  11  (57.9%)  were  male
nd  8  (42.1%)  were  female.  The  average  age  of  the  patients
as  58.1  years  (range,  20--81  years).  Each  of  the  pati-
nts  had  undergone  fundoplication  between  5  and  26
ears  prior  to  this  study  (average,  10.6  years).  Of  the
9  patients  studied,  14  had  a  good  esophageal  prepara-
ion  and  5  had  a  fair  preparation.  The  mean  esophageal
ransit  time  of  the  ECE  was  383.8  s  (SD,  404.6  s;  range,
--1211  s).
omparative  evaluation  of  esophageal  capsule
ndoscopy  and  methylene  blue  chromoendoscopy
esions  suspected  of  being  esophageal  cancer
here  was  only  a  single  case  of  a  lesion  suspected  of  being
sophageal  cancer.  It  was  identiﬁed  by  UGE  and  ECE.  ECE
dentiﬁed  four  additional  suspected  cases,  but  they  were
ot  conﬁrmed  by  UGE.  Thus,  ECE  had  a  sensitivity  of  100%,
 speciﬁcity  of  78%,  a  PPV  of  20%  and  an  NPV  of  100%.
ccording  to  the  Kappa  index,  the  correlation  between
CE  and  UGE  was  satisfactory  and  statistically  signiﬁcant
Table  1).
Table  1  Lesions  suspected  of  being  esophageal  cancer:  the
results  of  ECE  vs.  UGE.
Lesion  suspected
of being
esophageal  cancer
UGE  Total
No  Yes
ECE
No  14  0  14
Yes 4  1  5
Quantity  18  1  19
Sensitivity  100%
Speciﬁcity  78%
PPV 20%
NPV 100%
Accuracy  79%
Kappa (p-value)  0.27  (0.043)
ECE: esophageal capsule endoscopy; UGE: upper gastrointesti-
nal endoscopy; PPV: positive predictive value; NPV: negative
predictive value.
Kappa (p-value)  0.60  (0.004)
ECE: esophageal capsule endoscopy; UGE: upper gastrointesti-
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cnal endoscopy; PPV: positive predictive value; NPV: negative
predictive value.
After  the  analysis  of  esophageal  biopsies,  only  a  single
ase  of  early  esophageal  cancer  was  identiﬁed.  So  when  we
onsidered  the  outcomes  of  esophageal  biopsies  performed
uring  UGE  to  be  the  gold  standard  for  the  diagnosis  of
sophageal  cancer,  we  obtained  the  same  results  described
bove.
ength  and  pattern  of  Barrett’s  esophagus
e  evaluated  the  ability  of  ECE  to  correctly  identify  the
ength  of  the  BE  and  determined  that  this  method  had  an
ccuracy  level  of  89%  and  a  Kappa  index  of  agreement  of
.60  (moderate  agreement),  which  was  statistically  signiﬁ-
ant  (p  =  0.004)  (Tables  2  and  3).  Regarding  the  ability  of  ECE
o  correctly  detect  the  BE  pattern,  ECE  had  50%  sensitivity,
0%  speciﬁcity,  40%  PPV  and  86%  NPV  for  the  ﬁnger-like  type.
n  cases  of  circumferential  BE,  ECE  had  71%  sensitivity,  83%
peciﬁcity,  71%  PPV  and  83%  NPV.  For  cases  of  mixed  BE,  ECE
ad  a  sensitivity  of  63%,  speciﬁcity  of  82%,  PPV  of  71%  and
PV  of  75%.  The  Kappa  index  revealed  that  ECE  showed  a
oderate  agreement  with  UGE  in  the  identiﬁcation  of  cir-
umferential  and  mixed  BE,  but  there  was  no  signiﬁcant
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Table  4  Detection  of  ﬁnger-like  BE:  ECE  vs.  UGE.
Finger-like  BE  UGE  Total
No  Yes
ECE
No  12  2  14
Yes 3  2  5
Parameter  15  4  19
Sensitivity  50%
Speciﬁcity  80%
PPV 40%
NPV 86%
Accuracy  74%
Kappa (p-value)  0.28  (0.113)
ECE: esophageal capsule endoscopy; UGE: upper gastrointesti-
nal endoscopy; PPV: positive predictive value; NPV: negative
predictive value.
Table  5  Detection  of  circumferential  BE:  ECE  vs.  UGE.
Circumferential  BE  UGE  Total
No  Yes
ECE
No  10  2  12
Yes 2  5  7
Parameter  12  7  19
Sensitivity  71%
Speciﬁcity  83%
PPV 71%
NPV 83%
Accuracy  79%
Kappa (p-value)  0.55  (0.008)
Table  6  Detection  of  mixed  BE:  ECE  vs.  UGE.
Mixed  BE  UGE  Total
No  Yes
ECE
No  9  3  12
Yes 2  5  7
Parameter  11  8  19
Sensitivity  63
Speciﬁcity  82%
PPV 71%
NPV 75%
Accuracy  74%
Kappa (p-value)  0.45  (0.024)
ECE: esophageal capsule endoscopy; UGE: upper gastrointesti-
nal endoscopy; PPV: positive predictive value; NPV: negative
predictive value.
Table  7  Comparison  between  ECE  and  UGE  in  the  detection
of hiatal  hernia.
Hiatal  hernia UGE  Total
No  Yes
ECE
No  11  4  15
Yes 1  3  4
Quantity  12  7  19
Sensitivity  43%
Speciﬁcity  92%
PPV 75%
NPV 73%
Accuracy  74%
Kappa (p-value)  0.38  (0.037)
ECE: esophageal capsule endoscopy; UGE: upper gastrointesti-
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mECE: esophageal capsule endoscopy; UGE: upper gastrointesti-
nal endoscopy; PPV: positive predictive value; NPV: negative
predictive value.
agreement  in  the  identiﬁcation  of  ﬁnger-like  BE  (p  =  0.113)
(Tables  4--6).
Hiatal  hernia
Seven  cases  of  hiatal  hernia  were  identiﬁed  by  UGE,  whereas
ECE  identiﬁed  only  three  cases.  For  the  detection  of  hiatal
hernia,  ECE  had  sensitivity  of  43%,  speciﬁcity  of  92%,  PPV
of  75%  and  NPV  of  73%.  The  Kappa  index  was  0.38  (fair
agreement)  (Table  7).
Discomfort  and  complications
Of  the  19  patients  who  completed  the  study,  3  reported  min-
imal  discomfort  during  the  ingestion  of  the  ECE,  and  6  and
2  reported  minimal  and  moderate  discomfort,  respectively,
during  the  UGE.  A  greater  number  of  patients  reported  dis-
comfort  during  the  UGE  compared  with  the  ECE,  but  this
difference  was  not  statistically  signiﬁcant  (p  =  0.186).  With
respect  to  complications,  there  was  one  case  of  retention
of  the  ECE  in  the  esophagus.  In  this  case,  the  ECE  was  visu-
alized  and  then  removed  without  complications  during  the
UGE  examination;  this  patient  had  stenosis  of  the  distal
esophagus  and  was  excluded  from  the  study.
t
t
p
wnal endoscopy; PPV: positive predictive value; NPV: negative
predictive value.
iscussion
nce  a  patient  has  developed  BE,  he  or  she  will  always
ave  an  increased  risk  of  developing  esophageal  adeno-
arcinoma.  Several  studies  have  shown  that  neither  the
linical  treatment  of  BE  using  proton  pump  inhibitors
or  the  surgical  treatment  of  BE  with  fundoplication  pre-
ents  the  progression  of  BE  to  adenocarcinoma.9--11 Several
tudies  have  shown  that  patients  who  participated  in  endo-
copic  monitoring  programs  had  their  tumors  diagnosed  at
arlier  stages  and  generally  had  a  signiﬁcant  improvement  in
heir  survival  rate.20--22 Mainly  in  cases  of  intraepithelial  neo-
lasia  and  early  adenocarcinoma,  various  techniques  such
s  conventional  chromoendoscopy  and  optics  can  be  used  to
acilitate  the  identiﬁcation  of  BE.  In  this  study,  we  used  chro-
oendoscopy  with  methylene  blue  to  identify  BE  because
his  method  is  more  compatible  with  the  reality  of  our  coun-
ry,  given  that  few  Brazilian  or  South  American  endoscopy
roviders  have  access  to  high-resolution  video  endoscopes
ith  optical  chromoendoscopy.
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Although  capsule  endoscopy  is  considered  by  many  to  be
 front-line  method  for  the  diagnosis  of  diseases  of  the  small
ntestine,23,24 this  technique  has  proven  to  be  ineffective  for
he  assessment  of  esophageal  disorders  mainly  because  of
he  short  esophageal  transit  time,  the  low  frequency  of  cap-
ured  images  (two  per  second)  and  the  presence  of  only  one
amera.25 Thus,  ECE,  which  uses  two  cameras  with  speeds  of
--14  frames  per  second,  was  developed  to  overcome  these
imitations.  Initial  results  indicated  that  ECE  was  a  sensi-
ive,  speciﬁc  method  for  evaluating  esophageal  disorders  in
atients  with  symptoms  of  GERD.17,25 However,  later  studies
chieved  more  modest  results  for  the  ECE-based  diagnosis  of
sophageal  disorders.19,26,27 No  studies  have  yet  compared
he  efﬁcacy  of  the  ECE  and  UGE  methods  in  studying  the
haracteristics  of  BE  or  in  the  tracking  of  lesions  suspected
f  being  malignant  in  BE  patients  who  had  previously  under-
one  fundoplication.
In this  study,  the  average  esophageal  transit  time  was
83.8  s  (range,  2--1211  s),  which  is  higher  than  that  found
y  most  previous  studies.17,26,28 We  believe  that  this  dis-
repancy  is  due  to  the  prior  fundoplication  that  these
atients  had  undergone,  but  we  cannot  be  sure  that  a  longer
sophageal  transit  time  necessarily  contributes  to  better
isualization  of  the  esophageal  transition.
The  ECE  method  had  a  sensitivity  and  NPV  of  100%  for
he  detection  of  lesions  suspected  to  be  esophageal  cancer.
hus,  despite  the  lower  speciﬁcity  of  ECE  compared  with
GE  (78%  vs.  100%,  respectively),  the  use  of  ECE  produced
xcellent  results  in  terms  of  sensitivity  and  NPV,  the  most
mportant  indices  for  a  screening  test.  When  the  ability  of
CE  to  classify  the  length  of  BE  as  long  or  short  was  evalu-
ted,  ECE  had  an  accuracy  of  89%  with  higher  sensitivity  and
PV  for  long  BE  (94%  for  both  parameters)  than  for  short  BE.
egarding  the  accurate  identiﬁcation  of  the  BE  pattern,  ECE
ad  modest  results.  There  was  moderate  agreement  in  cases
f  circumferential  and  mixed  types  of  BE,  and  there  was  no
igniﬁcant  agreement  in  cases  of  columnar  ﬁnger-like  BE.
s  previously  reported  by  Sharma  et  al.,  ECE  is  not  a good
ethod  for  the  detection  of  hiatal  hernia.27 Our  ﬁndings
n  the  degree  of  discomfort  experienced  by  patients  dur-
ng  the  examinations,  although  not  statistically  signiﬁcant,
ere  consistent  with  those  reported  by  most  previous  stud-
es,  including  Eliakim  et  al.  and  Bhardwaj  et  al.17,19 Among
he  19  patients  included  in  the  ﬁnal  study  group,  there  were
o  cases  of  complications  during  the  two  endoscopic  proce-
ures.
Some  limitations  of  this  study  should  be  considered.  The
CE  used  in  this  study  is  a  ﬁrst  generation  capsule  model
PillCam  ESO),  which  captures  only  four  images  per  second.
t  is  possible  that  the  use  of  a  more  modern  capsule  endo-
cope,  such  as  the  PillCam  ESO  2,  which  is  capable  of  taking
4  pictures  per  second  and  has  a  greater  ﬁeld  of  vision,  could
mprove  the  results.  In  addition,  the  traditional  ingestion
rotocol  used  could  have  inﬂuenced  our  results.  A  new  inges-
ion  protocol  --  the  simpliﬁed  ingestion  protocol  --  appears
o  allow  greater  visualization  of  the  esophagogastric  junc-
ion,  as  demonstrated  by  De  Jonge  et  al.29 Moreover,  the
esults  of  the  ECE  examination  were  evaluated  by  a  single
nvestigator  in  the  present  work;  Lai  et  al.  demonstrated
hat  there  is  a  moderate  discrepancy  between  different
bservers  in  the  interpretation  of  capsule  endoscopy  exam-
nations  of  the  small  intestine.30 A  signiﬁcant  limiting  factorT.A.  Domingos  et  al.
f  ECE  is  its  inability  to  obtain  tissue  for  anatomopatholog-
cal  evaluation,  which  means  that  a  subsequent  UGE  biopsy
s  required  in  cases  where  there  are  lesions  suspected  of
alignancy.  In  the  near  future,  it  is  likely  that  the  capsule
ndoscope  will  be  remotely  controlled  by  the  examiner  and
ill  allow  for  tissue  samples  to  be  taken  from  potentially
alignant  sites  that  can  be  studied  for  anatomopatholo-
ies.
The  advantages  of  ECE  over  conventional  UGE,  such  as
onvenience,  tolerability,  a  minimum  of  time  away  from
ork,  and  safety,  are  undeniable.  However,  despite  the
dvantages  that  make  ECE  attractive,  this  method  cannot
urrently  be  recommended  as  a  ﬁrst  choice  to  monitor  BE.
n  the  other  hand,  we  believe  it  could  be  useful  for  patients
ho  have  contraindications  to  UGE  or  who  refuse  to  undergo
 conventional  UGE.  Further  studies  with  larger  sample  sizes
re  necessary  to  deﬁne  the  future  role  of  ECE  in  the  moni-
oring  of  BE.
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